 | | News Brief V
From the desk of MARY GILLESPIE
Vaniqa, marketed by Bristol-Myers Squibb and Gillette Company's, is a 15% eflornithine cream safely tested for inhibiting excess hair growth in females. Presently, submitted for FDA review the cream will be available through medical doctors (check with your doctor). Vaniqa, an irreversible enzyme blocker inhibits cell growth within the hair follicle. The body's continual production of the enzyme requires a twice a day application for maintenance. Opposed to the laser that currently serves only light skinned, dark hair patients this is safely effective on all individuals. Women participating in the clinical studies where allowed to keep up their facial shaving, waxing and tweezing -- a total of 70% had marked improvement in 24 weeks.
Artecoll, are injected non-biodegradeable microspheres that are too large to be rejected or migrate, considered to be permanent. Results take up to four months to evolve with no need for continual treatment. Indications for use are, acne scars, fill folds and wrinkles, primarily around the nose and mouth, augment the lips and correct any divots in the skin. This could be your answer to continually collagen maintenance. I do not have local doctors for your reference for this service at this time.
Until next time, Mary
|
| |
|
